Determining whether a drug manufacturing environment is stable, drifting, or developing a recurring loss-of-control signal requires integrated trend evaluation.
- Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
- How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
- The EU Overhauls Pharma Laws: What You Need To Know
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Closing The CAR-T Access Gap With Hospital-Based Manufacturing
- How To Stand Up A Hospital-Based CAR-T Manufacturing Network
- September 2026 — CDMO Opportunities And Threats Report
- An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Prevent The Risk Of Cross-Contamination With Microbial Colony Pickers
Explore a microbial colony picker that streamlines lab workflows to ensure rapid and accurate genetic library screening. Key features include UV sanitization, pin washing, and halogen drying, which meets GMP standards.
-
An Innovative, Modular Approach To Flexible Supply Chain Management
Learn how modular strategies, global coordination, and data-driven decisions help maintain continuity, compliance, and speed amid constant uncertainty.
-
Comparison Of Constant- And PulsedField Electrophoresis
Accurate sizing of large DNA fragments is crucial in long‑read sequencing. Examine how different electrophoresis methods perform with 10–20 kb smears and how to choose the most reliable approach.
-
Scaling Investigational Drug Services: A Case Study in Overcoming Operational Bottlenecks
Are operational bottlenecks holding back your research site? Explore a blueprint for automating investigational product workflows and giving staff time back for patient care.
-
The Automation Advantage: Reducing Risk In Cell Therapy Production
Automated bioprocessing platforms transform complex cell therapy workflows into scalable, fully compliant manufacturing pathways to lower costs and expand access.
-
Microbial Recovery And Flow Performance With Membranes
Compare membrane materials and pore sizes to assess their impact on flow rate and microbial recovery. See how fast filtration and ≥90% organism recovery offer guidance for selecting reliable membranes.
-
Accelerating Cell Therapy Discovery With High-Throughput Electroporation
Discover how high-throughput electroporation-based screening can compress your CAR-T optimization timeline while delivering reproducible, scale-ready results across multiple donor samples.
-
Sample Clean-Up After N-Linked Glycan Release And Labeling
Glycan profiling starts with effective clean-up. See how comparable recovery across key labeled glycans and sialylated glycan groups can support confident analysis while helping labs manage costs.
-
The AI-Ready Factory: How IT/OT Integration Transforms Manufacturing Data
Pharmaceutical manufacturers need more than raw production data to scale AI. Learn how contextualized, governed IT/OT integration can turn disconnected shop-floor signals into real-time decisions.
-
Why CGT Access Strategy Must Go Beyond Academic Medical Centers
Academic medical centers built the foundation for CGT delivery, but their reach has a ceiling. Closing the access gap means rethinking how these therapies move through community hospital networks at scale.
NEWSLETTER ARCHIVE
- 11.06.26 -- New Podcast Episodes: AI And Digital Twins In Bioprocessing, Tomorrow's CNS Breakthroughs, Advancing CGT Delivery
- 11.06.26 -- Is Your Supply Chain Ready For The End Of Class VI?
- 11.05.26 -- Fixing High-Density Process Bottlenecks In Vector Production
- 11.05.26 -- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- 11.04.26 -- How The Right Media Boosts AAV Titer And Yield
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

